Latest debt-to-equity ratio
Regencell Bioscience Debt-to-equity ratio
Direct answer
Regencell Bioscience's debt-to-equity ratio is 2.22%.
The verified market snapshot reports 2.22%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 25, 2026.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2.22%
Explore related company data
View Regencell Bioscience's market capitalizationView Regencell Bioscience's price-to-book ratioView Regencell Bioscience's return on equityView Regencell Bioscience's dividend yieldView Regencell Bioscience's 52-week price rangeView Regencell Bioscience's profit marginView all Regencell Bioscience key metricsReturn to Regencell Bioscience profile